TABLE 3.
Surface under the cumulative ranking curve (SUCRA) probabilities (%) and mean rank of interventions.
| Treatments | Successful feeding rate | Postpyloric intubation success | GRV | Any reported adverse events | ||||
|---|---|---|---|---|---|---|---|---|
| SUCRA | MeanRank | SUCRA | MeanRank | SUCRA | MeanRank | SUCRA | MeanRank | |
| Combine | 100.0 % | 1.0 | 76.4 % | 1.9 | 58.5% | 1.8 | 7.5% | 4.7 |
| Erythromycin | 49.4% | 2.0 | 56.5% | 2.7 | 69.3% | 1.6 | 35.3% | 3.6 |
| Metoclopramide | 0.6% | 3.0 | 56.0% | 2.8 | 22.3% | 2.6 | 65.6% | 2.4 |
| Placebo | / | / | 43.0% | 3.3 | / | / | 80.0% | 1.8 |
| Blank control | / | / | 18.0% | 4.3 | / | / | 61.6% | 2.5 |